Glucostratus
Financiado
Bringing the benefits of interactive digital health to the care of elderly perso...
Bringing the benefits of interactive digital health to the care of elderly persons with diabetes
Diabetes is a growing problem globally, with a total number of diabetes affected people of 60 million (2015) in Europe, expected to grow up to 71 million in 2040. This problem particularly affects elderly people, as the prevalence...
Diabetes is a growing problem globally, with a total number of diabetes affected people of 60 million (2015) in Europe, expected to grow up to 71 million in 2040. This problem particularly affects elderly people, as the prevalence of diabetes increases to up to 20% at age 70+. Addressing these challenges is of utmost importance considering that diabetes will be the seventh leading cause of death in 2030 and the
proportion of elderly people is rising steadily. Most importantly, elderly diabetes patients have special needs, as for example diabetes-related tasks (e.g. blood glucose tests and injecting insulin) have to be handled by visiting home care nurses who also have the task of entering the results to medical records.
The current smartphone solutions are not suited for elderly patients since they require fluency with smartphones and Bluetooth device connections. Glucostratus has developed a remote blood glucose monitoring system (Smart + Balance) to measure glucose levels of elderly patients, while allowing their remote follow up, guidance and better patient↔healthcare professional communication. The Smart glucometer has a built-in 3G mobile data connection which automatically sends the readings to the cloud platform (Balance) through an encrypted connection. Balance is thus a secure data storage, with embedded functionalities for data sharing (patient↔healthcare professional) and for data analysis & decision support. The concept aims to improve: i) support that diabetes patients are getting through remote monitoring and automated guidance based on their real-time blood glucose data and individual settings; ii) availability of comprehensive blood glucose history as well as analysis for decision support to healthcare professionals; iii) ability of healthcare professionals to intervene early when a patient is not meeting treatment targets; iv) workflows and cost-effectiveness of diabetes-related nurse activities in home care; and (v) easy-to- use system.
ver más
Duración del proyecto: 7 meses
Fecha Inicio: 2018-04-27
Fecha Fin: 2018-11-30
Fecha Fin: 2018-11-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2018-11-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
71K€
Líder del proyecto
GLUCOSTRATUS OY
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
166.54K€ |
Participante